Rebiopsy and Acquired Mutations Following Progression in Non-Small Cell Lung Cancer
2 Visningar
• 07/14/23
0
0
Bädda in
administrator
Prenumeranter
Anne S. Tsao, MD, Mark A. Socinski, MD, Corey J. Langer, MD, Alan B. Sandler, MD, and David Gandara, MD, discuss the need to perform a second biopsy to check for the loss or acquisition of mutations in non-small cell lung cancer following progression.
For more from this conversation: http://www.onclive.com/peer-ex....change/nsclc-advance
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna